{"entity":{"id":"3c331f86-b5b2-56dc-bfaa-e22c9ccfb64a","name":"DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.","type":"Company","kind":"company","jurisdiction":"US","identifier":"sec:0001565099","risk":"LOW","flags":[],"registry_profile":null},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"tenpercentownerother","share":null,"subsidiary":{"id":"d4446aa6-5f55-5cb3-b3eb-17603df94b04","name":"CAS MEDICAL SYSTEMS INC","type":"Company","kind":"company","identifier":"sec:0000764579"}},{"role":"tenpercentownerother","share":null,"subsidiary":{"id":"d54e2413-cebc-5e01-bc86-3b7d84bd9785","name":"Protara Therapeutics, Inc.","type":"Company","kind":"company","identifier":"sec:0001359931"}},{"role":"tenpercentownerother","share":null,"subsidiary":{"id":"fd0a99e9-8a40-5e51-b104-33af8fce8d8a","name":"Vanda Pharmaceuticals Inc.","type":"Company","kind":"company","identifier":"sec:0001347178"}},{"role":"tenpercentownerother","share":null,"subsidiary":{"id":"e266421a-23a3-55f8-9ed4-831e91084e35","name":"DICERNA PHARMACEUTICALS INC","type":"Company","kind":"company","identifier":"sec:0001399529"}},{"role":"tenpercentownerother","share":null,"subsidiary":{"id":"2e479e2e-9ea8-5cf7-a7a3-5d423cc5e323","name":"Adverum Biotechnologies, Inc.","type":"Company","kind":"company","identifier":"sec:0001501756"}},{"role":"tenpercentownerother","share":null,"subsidiary":{"id":"754008b1-41a4-5108-a53a-ffe8793fb4b5","name":"LOXO ONCOLOGY, INC.","type":"Company","kind":"company","identifier":"sec:0001581720"}},{"role":"tenpercentownerother","share":null,"subsidiary":{"id":"e1e0b3e6-2d9e-542c-92fd-023aa32b157d","name":"TRIVASCULAR TECHNOLOGIES, INC.","type":"Company","kind":"company","identifier":"sec:0001432732"}},{"role":"tenpercentownerother","share":null,"subsidiary":{"id":"a0ac14ce-2fa2-5888-afaa-4d29b79abd4d","name":"AUSPEX PHARMACEUTICALS, INC.","type":"Company","kind":"company","identifier":"sec:0001454189"}},{"role":"tenpercentownerother","share":null,"subsidiary":{"id":"3613414e-93b8-5896-b09f-71a1296ab7fb","name":"PERNIX SLEEP, INC.","type":"Company","kind":"company","identifier":"sec:0001339455"}},{"role":"tenpercentownerother","share":null,"subsidiary":{"id":"6af4045d-235f-51fe-ab3b-8f44dd71f57c","name":"NXSTAGE MEDICAL, INC.","type":"Company","kind":"company","identifier":"sec:0001333170"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"financials":null,"sources":[],"access":{"tier":"free","note":"Free tier: identity, cross-source links, 1-hop subsidiaries, risk/sanctions, latest financials and provenance. The full multi-hop UBO chain, itemised assets (vessels/aircraft/securities/real estate) and financial history unlock with a paid API key or a one-off dossier — whiteintel.dev/pricing."},"source":"corpus"}